Search

Your search keyword '"Dubus, J.-C."' showing total 184 results
Start Over Author "Dubus, J.-C." Publication Year Range Last 10 years
184 results on '"Dubus, J.-C."'

23. Childhood asthma outcomes during the COVID-19 pandemic:findings from the PeARL multinational cohort

Author

Papadopoulos, N. G. (Nikolaos G.), Mathioudakis, A. G. (Alexander G.), Custovic, A. (Adnan), Deschildre, A. (Antoine), Phipatanakul, W. (Wanda), Wong, G. (Gary), Xepapadaki, P. (Paraskevi), Abou-Taam, R. (Rola), Agache, I. (Ioana), Castro-Rodriguez, J. A. (Jose A.), Chen, Z. (Zhimin), Cros, P. (Pierrick), Dubus, J.-C. (Jean-Christophe), El-Sayed, Z. A. (Zeinab Awad), El-Owaidy, R. (Rasha), Feleszko, W. (Wojciech), Fierro, V. (Vincenzo), Fiocchi, A. (Alessandro), Garcia-Marcos, L. (Luis), Goh, A. (Anne), Hossny, E. M. (Elham M.), Huerta Villalobos, Y. R. (Yunuen R.), Jartti, T. (Tuomas), Le Roux, P. (Pascal), Levina, J. (Julia), Lopez Garcia, A. I. (Aida Ines), Ramos, A. M. (Angel Mazon), Morais-Almeida, M. (Mario), Murray, C. (Clare), Nagaraju, K. (Karthik), Nagaraju, M. K. (Major K.), Navarrete Rodriguez, E. M. (Elsy Maureen), Namazova-Baranova, L. (Leyla), Nieto Garcia, A. (Antonio), Pozo Beltran, C. F. (Cesar Fireth), Ratchataswan, T. (Thanaporn), Rivero Yeverino, D. (Daniela), Rodriguez Zagal, E. (Erendira), Schweitzer, C. E. (Cyril E.), Tulkki, M. (Marleena), Wasilczuk, K. (Katarzyna), and Xu, D. (Dan)

Subjects
immune system diseases, childhood asthma, coronavirus, COVID-19, respiratory tract diseases
Abstract

Background: The interplay between COVID-19 pandemic and asthma in children is still unclear. We evaluated the impact of COVID-19 pandemic on childhood asthma outcomes. Methods: The PeARL multinational cohort included 1,054 children with asthma and 505 non-asthmatic children aged between 4 and 18 years from 25 pediatric departments, from 15 countries globally. We compared the frequency of acute respiratory and febrile presentations during the first wave of the COVID-19 pandemic between groups and with data available from the previous year. In children with asthma, we also compared current and historical disease control. Results: During the pandemic, children with asthma experienced fewer upper respiratory tract infections, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks, and hospitalizations due to asthma, in comparison with the preceding year. Sixty-six percent of asthmatic children had improved asthma control while in 33% the improvement exceeded the minimal clinically important difference. Pre-bronchodilatation FEV₁ and peak expiratory flow rate were improved during the pandemic. When compared to non-asthmatic controls, children with asthma were not at increased risk of LRTIs, episodes of pyrexia, emergency visits, or hospitalizations during the pandemic. However, an increased risk of URTIs emerged. Conclusions: Childhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent.

Published
2021

24. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Author

Papadopoulos, N.G. Mathioudakis, A.G. Custovic, A. Deschildre, A. Phipatanakul, W. Wong, G. Xepapadaki, P. Abou-Taam, R. Agache, I. Castro-Rodriguez, J.A. Chen, Z. Cros, P. Dubus, J.-C. El-Sayed, Z.A. El-Owaidy, R. Feleszko, W. Fierro, V. Fiocchi, A. Garcia-Marcos, L. Goh, A. Hossny, E.M. Huerta Villalobos, Y.R. Jartti, T. Le Roux, P. Levina, J. López García, A.I. Ramos, Á.M. Morais-Almeida, M. Murray, C. Nagaraju, K. Nagaraju, M.K. Navarrete Rodriguez, E.M. Namazova-Baranova, L. Nieto Garcia, A. Pozo Beltrán, C.F. Ratchataswan, T. Rivero Yeverino, D. Rodríguez Zagal, E. Schweitzer, C.E. Tulkki, M. Wasilczuk, K. Xu, D. Alekseeva, A. Almeida, B. Andre, M. Arimova, P. Blonde, A. Cunningham, A. Da Mota, S. Efendieva, K. Kalugina, V. Kiefer, S. Klein, A. López, C.G.C. López, J.J.R. Moratellti, C. Fuentes Pérez, M. Simermann, M. Tapia, J.S.P. Tatopoulos, A. Vishneva, E. Volkov, Κ. Bacharier, L. Bonini, M. Craig, T. Diamant, Z. Ducharme, F.M. Gern, J.E. Grigg, J. Hamelmann, E.H. Hedlin, G. Jartti, T. Kalayci, O. Kaplan, A. Konradsen, J. Kuna, P. Lau, S. Le Souef, P. Lemanske, R.F. Makela, M.J. Matricardi, P.M. Gómez, R.-M. Miligkos, M. Pitrez, P.M.C. Price, D. Pohunek, P. Roberts, G.C. Sheikh, A. Tsiligianni, I. Turner, S. Valiulis, A. Winders, T. Yusuf, O.M. Zar, H. PeARL collaborators, on behalf of the PeARL Think Tank

Subjects
respiratory tract diseases
Abstract

Background: The interplay between COVID-19 pandemic and asthma in children is still unclear. We evaluated the impact of COVID-19 pandemic on childhood asthma outcomes. Methods: The PeARL multinational cohort included 1,054 children with asthma and 505 non-asthmatic children aged between 4 and 18 years from 25 pediatric departments, from 15 countries globally. We compared the frequency of acute respiratory and febrile presentations during the first wave of the COVID-19 pandemic between groups and with data available from the previous year. In children with asthma, we also compared current and historical disease control. Results: During the pandemic, children with asthma experienced fewer upper respiratory tract infections, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks, and hospitalizations due to asthma, in comparison with the preceding year. Sixty-six percent of asthmatic children had improved asthma control while in 33% the improvement exceeded the minimal clinically important difference. Pre-bronchodilatation FEV1 and peak expiratory flow rate were improved during the pandemic. When compared to non-asthmatic controls, children with asthma were not at increased risk of LRTIs, episodes of pyrexia, emergency visits, or hospitalizations during the pandemic. However, an increased risk of URTIs emerged. Conclusion: Childhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent. © 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Published
2021

28. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

Author

Papadopoulos, N.G. Custovic, A. Deschildre, A. Mathioudakis, A.G. Phipatanakul, W. Wong, G. Xepapadaki, P. Agache, I. Bacharier, L. Bonini, M. Castro-Rodriguez, J.A. Chen, Z. Craig, T. Ducharme, F.M. El-Sayed, Z.A. Feleszko, W. Fiocchi, A. Garcia-Marcos, L. Gern, J.E. Goh, A. Gómez, R.M. Hamelmann, E.H. Hedlin, G. Hossny, E.M. Jartti, T. Kalayci, O. Kaplan, A. Konradsen, J. Kuna, P. Lau, S. Le Souef, P. Lemanske, R.F. Mäkelä, M.J. Morais-Almeida, M. Murray, C. Nagaraju, K. Namazova-Baranova, L. Garcia, A.N. Yusuf, O.M. Pitrez, P.M.C. Pohunek, P. Pozo Beltrán, C.F. Roberts, G.C. Valiulis, A. Zar, H.J. Taam, R.A. Azuara, H. Brouard, J. Cros, P. De Lira, C. Dubus, J.-C. Dunder, T. Efendieva, K. Egron, C. Emeryk, A. Huerta Villalobos, Y.R. Karen, N. Le Roux, P. Levina, J. Medley, M. Najaraju, M. Yeverino, D.R. Ruotsalainen, M. Szefler, S. Schweitzer, C. Benhumea, B.V. Villarreal, R. Weiss, L. Zawadzka-Krajewska, A.

Abstract

Background: It is unclear whether asthma may affect susceptibility or severity of coronavirus disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic. Objective: To describe the impact of the COVID-19 pandemic on pediatric asthma services and on disease burden in their patients. Methods: An online survey was sent to members of the Pediatric Asthma in Real Life think tank and the World Allergy Organization Pediatric Asthma Committee. It included questions on service provision, disease burden, and the clinical course of confirmed cases of COVID-19 infection among children with asthma. Results: Ninety-one respondents, caring for an estimated population of more than 133,000 children with asthma, completed the survey. COVID-19 significantly impacted pediatric asthma services: 39% ceased physical appointments, 47% stopped accepting new patients, and 75% limited patients' visits. Consultations were almost halved to a median of 20 (interquartile range, 10-25) patients per week. Virtual clinics and helplines were launched in most centers. Better than expected disease control was reported in 20% (10%-40%) of patients, whereas control was negatively affected in only 10% (7.5%-12.5%). Adherence also appeared to increase. Only 15 confirmed cases of COVID-19 were reported among the population; the estimated incidence is not apparently different from the reports of general pediatric cohorts. Conclusions: Children with asthma do not appear to be disproportionately affected by COVID-19. Outcomes may even have improved, possibly through increased adherence and/or reduced exposures. Clinical services have rapidly responded to the pandemic by limiting and replacing physical appointments with virtual encounters. © 2020 American Academy of Allergy, Asthma & Immunology

Published
2020

32. Pseudorhonas aeruginosa in post-piercing perichondritis: Two case reports

Author

Lelong, A-G., Mallet, S., Le Treut, C., Dubus, J-C., Carsin, A., Bosdure, E., Laboratoire de recherche en sciences de gestion Panthéon-Assas (LARGEPA), Université Panthéon-Assas (UP2), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), and INSB-INSB-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience; The frequency of body piercing has increased in France over the past few years, particularly among teenagers. Piercing can be performed at different sites on the body, especially in the cartilage of the ears. We relate two cases of Pseudomonas aeruginosa chondritis. A 10 year retrospective study at the Marseille University Hospital found no additional pediatric cases. These infectious complications can sometimes be necrotizing. It is therefore important to inform the medical staff on the hygiene measures that need to be respected and the patients on the treatment to follow after the piercing as well as the signs to watch for, possibly indicating chondritis. The esthetic consequences depend on early diagnosis. (C) 2017 Elsevier Masson SAS. All rights reserved.

Published
2017

33. Health care providers' knowledge and abilities to use inhalation devices and spacers

Author

Orfanos, S., Carsin, A., Baravalle, M., Dubus, J. -C., Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), and INSB-INSB-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, education
Abstract

International audience; Introduction - Inhaled therapy is the mainstay of asthma treatment due to its local and rapid action. However, its efficiency relies on the teaching of a good inhalation technique by health care providers. We assessed health care providers' knowledge and practical skills in the use of inhalation devices. Methods. - An observational multicenter study was conducted in the pulmonology and paediatric wards in Marseille. The departments' common practices, theoretical knowledge and practical skills were assessed through a questionnaire and a demonstration using a spacer device. Results. - Forty health care providers were interviewed (9 attending physicians, 14 residents, 16 nurses and 1 physiotherapist), in 8 different pulmonology and paediatric wards. A total of 42.5% reported previous training in inhalation device technique. When evaluating theoretical knowledge, we found a mean of 54% correct answers. Attending physicians did significantly better than residents and nurses. With regard to practical skills, we found a mean of 1.12 failed steps out of 7. Here again attending physicians did significantly better than residents and nurses. Conclusion. - Based on the results of our study, we recommend that attending physicians provide training of inhalation technique to nurses and residents, as they did significantly better theoretically and practically. (C) 2016 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Published
2017

34. Bench-test evaluation of spacer devices for fluticasone delivery to infants

Author

Pourchez, J., Leclerc, L., Sarry, G., Vergnon, J. -M., Dubus, J. C., Centre Ingénierie et Santé (CIS-ENSMSE), École des Mines de Saint-Étienne (Mines Saint-Étienne MSE), Institut Mines-Télécom [Paris] (IMT)-Institut Mines-Télécom [Paris] (IMT), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Abstract

International audience; Introduction. - Use of a spacer device to optimize the delivery of fluticasone to infants with asthma is an important issue and clinicians require guidance around the choice of device. This in vitro study characterizes the particle size and the fluticasone delivery via 9 spacers. Methods. - We used an in vitro infant nasal cast with two different inspiratory flow rates (50 and 100 mL/s). Fluticasone particle size in the aerosol was evaluated by laser diffractometry and tracheal deposition by spectrophotometric assay. Results. - Significant differences in particle size were observed between the 9 spacers (similar D50 but D90 from 5.65 +/- 0.65 to 8.80 +/- 1.35 mu m). A 75% or higher respirable fraction was obtained for only 5 spacers. The 50 mL/s flow rate lead to the best drug delivery. At this flow, OptiChamber (R) (62 +/- 3 %) and Vortex (R) (91 +/- 8.5%) had a tracheal deposition over 50% of the initial dose of fluticasone, although the 7 other spacers exhibited a fluticasone deposition less than 25%. Discussion. - This study shows a wide variation of drug delivery between the 9 spacers studied. We demonstrate that a low inspiratory flow and a spacer showing antistatic properties facilitate drug delivery. (C) 2016 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Published
2017

36. Complementary exams in child abuse: A French national study in 2015

Author

Ledoyen, A., Bresson, V., Dubus, J. -C., Tardieu, S., Petit, P., Chabrol, B., Bosdure, E., Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Institut de recherche en astrophysique et planétologie (IRAP), Institut national des sciences de l'Univers (INSU - CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Observatoire Midi-Pyrénées (OMP), Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de génétique des maladies rares. Pathologie moleculaire, etudes fonctionnelles et banque de données génétiques (LGMR), Université Montpellier 1 (UM1)-IFR3, Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Abstract

International audience; Introduction. Even if there are HAS (French National Health Authority) guidelines on shaken baby syndrome, many other child abuse situations are not included in these recommendations. The aim of this study was to invent the complementary exams in cases of child abuse in France and compare the practice to existing guidelines. Material and methods. This was a multicenter study by email to 128 French hospitals (35 university hospitals and 93 general hospitals) that receives children in emergency and hospitalization settings. Three child abuse clinical situations were included in a clinical case multiple-choice format concerning the further explorations. We described the main results and evaluated their adherence to the HAS protocol for case 1. Results. Of 128 hospitals surveyed, 104 responded, for an 81% response rate, which corresponded to 274 doctors. Analysis of the results showed great heterogeneity in practices. The majority of physicians (99%) performed systematic explorations in the situation of physical abuse, while only 27% undertook such exams in situations of serious neglect. The situation of sexual abuse was the most consensual in terms of diagnostic tests for the detection of sexually transmitted diseases, but other types of associated abuse were not sought. In the first case, the HAS guidelines were respected in less than half of the cases for all complementary exams except the eye fundus exam. Abdominal imaging was insufficiently performed (40% of cases). Examinations that were not indicated were still prescribed. Moreover, siblings under 2 years of age were examined in only one-third of cases (n = 88/274; 32%). Practices were not influenced by the age of the child. Conclusion. This study illustrates the heterogeneity in the use of complementary exams in cases of child abuse in France. Common protocols throughout the country would be useful, standardizing the most relevant exams for potential medical-legal issues, and facilitating exchanges concerning practices between different centers. (C) 2016 Elsevier Masson SAS. All rights reserved.

Published
2016

37. Fat overload syndrome

Author

Picon, J., Carsin, A., Baravalle-Einaudi, M., Coste, M. -E., Wasier, A. -P., Stremler-Le Bel, N., Bosdure, E., Dubus, J. -C., Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Abstract

International audience; We report the case of a 21-month-old child suffering from pulmonary fibrosis, who presented with acute respiratory distress and liver damage, due to an accidental overdose of intravenous lipid emulsion. This poisoning is a rare entity, whose potential severity and almost exclusive iatrogenic effect deserve to be remembered. (C) 2016 Elsevier Masson SAS. All rights reserved.

Published
2016

38. Asthma in infants and young children: What are we talking about?

Author

Dubus, J. -C., Baravalle-Einaudi, M., Sterling, B., Carsin, A., Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, ComputingMilieux_MISCELLANEOUS
Abstract

International audience; no abstract

Published
2016

39. Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Societe de Pneumologie de Langue Francaise (SPLF)

Author

Raherison, C., Bourdin, A., Bonniaud, P., Deslée, G., Garcia, G., Leroyer, C., Taillé, C., de Blic, J., Dubus, J.-C., Tillié-Leblond, I., Chanez, Pascal, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université Bordeaux Segalen - Bordeaux 2, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Lipides - Nutrition - Cancer (U866) (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA), Service des maladies respiratoires [CHU de Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Protéines de choc thermique : mort cellulaire, différenciation cellulaire et propriétés tumorigéniques (U866, Cancer, équipe 3), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA)-Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA), Hôpital Maison Blanche, Centre Hospitalier Universitaire de Reims (CHU Reims), Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique, Centre Chirurgical Marie Lannelongue (CCML)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Cavale Blanche, Service de Pneumologie [Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Centre de Compétence pour les Maladies Pulmonaires Rares, Service de Pneumologie Allergologie [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Département des maladies respiratoires (MARSEILLE - DMR), and Assistance Publique - Hôpitaux de Marseille (APHM)

Subjects
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV]Life Sciences [q-bio], ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2016

43. Hétérogénéité de l’atteinte respiratoire associée aux mutations de NK2 homeobox 1

Author

Nattes, E., primary, Lejeune, S., additional, Carsin, A., additional, Borie, R., additional, Gibertini, I., additional, Balinotti, J., additional, Nathan, N., additional, Marchand-Adam, S., additional, Thumerelle, C., additional, Fauroux, B., additional, Houdouin, V., additional, Delestrain, C., additional, Louha, M., additional, Couderc, R., additional, De Becdelievre, A., additional, Fanen, P., additional, Funalot, B., additional, Crestani, B., additional, Deschildre, A., additional, Dubus, J.-C., additional, and Epaud, R., additional

Published
2017
Full Text
View/download PDF

49. Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)

Author

Levy, Mark L, primary, Dekhuijzen, P N R, additional, Barnes, P J, additional, Broeders, M, additional, Corrigan, C J, additional, Chawes, B L, additional, Corbetta, L, additional, Dubus, J C, additional, Hausen, Th, additional, Lavorini, F, additional, Roche, N, additional, Sanchis, J, additional, Usmani, Omar S, additional, Viejo, J, additional, Vincken, W, additional, Voshaar, Th, additional, Crompton, G K, additional, and Pedersen, Soren, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results